Cyril Gay

Dr
Cyril
Gay

Senior National Program Leader
Agricultural Research Service, United States Department of Agriculture
Email 
cyril.gay [at] usda.gov
Biography

Dr. Gay obtained a B.Sc. in Chemistry and a Doctor of Veterinary Medicine from Auburn University, and a Ph.D. in Microbiology from The George Washington University. Dr. Gay has worked in the animal health research field for the last 25 years holding several positions of increasing responsibility in the federal government and the pharmaceutical industry. As Chief, Biotechnology Section, Center for Veterinary Biologics (CVB), United States Department of Agriculture (USDA), Dr. Gay developed the procedures for licensing molecular vaccines that led to the first license for a live recombinant vectored vaccine. In the pharmaceutical industry (SmithKline Beecham and Pfizer Animal Health), Dr. Gay led several cross-functional teams that successfully developed and licensed veterinary vaccines for companion animals and livestock. As Director, Global Product Development, Pfizer Inc., Dr. Gay developed strategic and tactical plans that interfaced R&D, clinical development, manufacturing, marketing, and product life-cycle management. Dr. Gay joined Agricultural Research Service (ARS), USDA, in 2002. Dr. Gay currently holds the position of Senior National Program Leader and provides program direction and national coordination for the Department’s intramural animal health research program, with focus on eight research laboratories located in Ames, Iowa, East Lansing, Michigan, Clay Center, Nebraska, Athens, Georgia, Orient Point, New York, Beltsville, Maryland, Pullman, Washington, and Manhattan, Kansas. Dr. Gay provides technical support within the interagency in the implementation of the President’s National Strategy for Countering Biological Threats, including the National Bio and Agro Defense Facility (NBAF). Dr. Gay launched the Global African Swine Fever Research Alliance (GARA) in 2013 and currently serves as its Executive Secretary. Dr. Gay also serves as the Executive Secretary of the Global Foot-and-Mouth Research Alliance (GFRA). Dr. Gay was the 2010 recipient of the USDA Secretary’s Honors Award for interagency response to the pandemic H1N1 influenza outbreak; the ARS Special Administrator’s Award for outstanding and rapid research support for pandemic H1N1; the USDA Secretary’s Honor Award for Emergency Response to the 2013 Chinese H7N9 avian influenza outbreak, and received a U.S Presidential Rank Award in 2017.

Research interests

Vaccine discovery and vaccine development

Projects you're working on

Development of vaccines for African Swine Fever and FMD.

Discipline
Bacteriology Bio-manufacturing Challenge model development Challenge study design Clinical trials – efficacy Clinical trials – safety Epidemiology Ethics Formulation technology Immunology – B-cells Immunology – T-cells Immunology – innate Molecular biology Parasitology QC test development Quality assurance Registration Regulation Safety evaluation Structural biology Systems biology Virology
Host species
Buffalo Cattle Fish Horses Pigs Poultry Small ruminants Wildlife Zoonoses
Pathogen
Bacteria BacteriaBrucella BacteriaClostridia BacteriaE. coli BacteriaErysipelas BacteriaLeptospira BacteriaM. hyo BacteriaMycobacteria bovis BacteriaSalmonella BacteriaYersinia Parasites ParasitesBabesia ParasitesEimeria ParasitesTheileria annulata Viruses VirusesAdenovirus VirusesAfrican horse sickness virus VirusesAfrican swine fever virus VirusesArboviruses VirusesArteriviruses VirusesBluetongue virus VirusesBovine ephemeral fever virus VirusesBovine viral diarrhoea VirusesClassical swine fever virus VirusesCoronavirus VirusesCrimean-Congo haemorrhagic fever virus VirusesFoot-and-mouth disease virus VirusesInfectious bursal disease virus VirusesInfluenza virus VirusesMareks disease virus VirusesNewcastle disease virus VirusesNipah virus VirusesParainfluenza virus VirusesParamyxoviruses VirusesParvovirus VirusesPeste des petits ruminants virus VirusesPorcine reproductive and respiratory syndrome virus VirusesRespiratory syncytial virus VirusesRetroviruses VirusesRift Valley fever virus
Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Clinical trials Correlates of protection – immunomonitoring Field trials Pre-clinical trials Vaccine delivery